These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15998542)

  • 1. Age-dependent (+)MDMA-mediated neurotoxicity in mice.
    Reveron ME; Monks TJ; Duvauchelle CL
    Neurotoxicology; 2005 Dec; 26(6):1031-40. PubMed ID: 15998542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early loss of dopaminergic terminals in striosomes after MDMA administration to mice.
    Granado N; Escobedo I; O'Shea E; Colado I; Moratalla R
    Synapse; 2008 Jan; 62(1):80-4. PubMed ID: 17960765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of crowding, temperature and age on glia activation and dopaminergic neurotoxicity induced by MDMA in the mouse brain.
    Frau L; Simola N; Porceddu PF; Morelli M
    Neurotoxicology; 2016 Sep; 56():127-138. PubMed ID: 27451954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression and Persistence of Neurotoxicity Induced by MDMA in Dopaminergic Regions of the Mouse Brain and Association with Noradrenergic, GABAergic, and Serotonergic Damage.
    Costa G; Morelli M; Simola N
    Neurotox Res; 2017 Nov; 32(4):563-574. PubMed ID: 28597409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between core body temperature and 3,4-methylenedioxymethamphetamine metabolism in rats: implications for neurotoxicity.
    Goni-Allo B; O Mathúna B; Segura M; Puerta E; Lasheras B; de la Torre R; Aguirre N
    Psychopharmacology (Berl); 2008 Apr; 197(2):263-78. PubMed ID: 18074122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of dopamine to mitochondrial complex I inhibition and dopaminergic deficits caused by methylenedioxymethamphetamine in mice.
    Barros-Miñones L; Goñi-Allo B; Suquia V; Beitia G; Aguirre N; Puerta E
    Neuropharmacology; 2015 Jun; 93():124-33. PubMed ID: 25666033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.
    Lizarraga LE; Cholanians AB; Phan AV; Herndon JM; Lau SS; Monks TJ
    Toxicol Sci; 2015 Jan; 143(1):209-19. PubMed ID: 25370842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice.
    Granado N; O'Shea E; Bove J; Vila M; Colado MI; Moratalla R
    J Neurochem; 2008 Nov; 107(4):1102-12. PubMed ID: 18823368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration.
    Porceddu PF; Ishola IO; Contu L; Morelli M
    Neurotox Res; 2016 Jul; 30(1):101-9. PubMed ID: 27251371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity.
    Riezzo I; Cerretani D; Fiore C; Bello S; Centini F; D'Errico S; Fiaschi AI; Giorgi G; Neri M; Pomara C; Turillazzi E; Fineschi V
    J Neurosci Res; 2010 Mar; 88(4):905-16. PubMed ID: 19798748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
    Camarasa J; Pubill D; Escubedo E
    Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent Inhibition of Vesicular Monoamine Transporter 2 Does Not Protect Against 3,4-Methylenedioxymethamphetamine (Ecstasy) Induced Neurotoxicity.
    Cholanians AB; Phan AV; Lau SS; Monks TJ
    Toxicol Sci; 2019 Jul; 170(1):157-166. PubMed ID: 30923810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loud noise enhances nigrostriatal dopamine toxicity induced by MDMA in mice.
    Gesi M; Ferrucci M; Giusiani M; Lenzi P; Lazzeri G; Alessandrì MG; Salvadorini A; Fulceri F; Pellegrini A; Fornai F; Paparelli A
    Microsc Res Tech; 2004 Jul; 64(4):297-303. PubMed ID: 15481049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").
    Green AR; Mechan AO; Elliott JM; O'Shea E; Colado MI
    Pharmacol Rev; 2003 Sep; 55(3):463-508. PubMed ID: 12869661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment with supraphysiological levels of corticosterone enhances D-MDMA-induced dopaminergic neurotoxicity in the C57BL/6J female mouse.
    Johnson EA; O'Callaghan JP; Miller DB
    Brain Res; 2002 Apr; 933(2):130-8. PubMed ID: 11931857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strenuous exercise aggravates MDMA-induced skeletal muscle damage in mice.
    Duarte JA; Leão A; Magalhães J; Ascensão A; Bastos ML; Amado FL; Vilarinho L; Quelhas D; Appell HJ; Carvalho F
    Toxicology; 2005 Jan; 206(3):349-58. PubMed ID: 15588925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain concentrations of d-MDMA are increased after stress.
    Johnson EA; O'Callaghan JP; Miller DB
    Psychopharmacology (Berl); 2004 May; 173(3-4):278-86. PubMed ID: 14735292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.